Peritoneal epithelial lesions associated with proliferative serous tumours of ovary

Histopathology
W T McCaugheyI Dardick

Abstract

The peritoneal epithelial lesions in 40 cases of proliferating ovarian serous tumour are described. The lesions were varied and of both neoplastic and non-neoplastic form. The most common was serous tumour similar to that in the associated ovarian neoplasm. Tumour of this type was present in some or all of the peritoneal lesions in 77.5% of cases. In nearly two-thirds, the tumour was superficial; in the rest it invaded omentum. Occasionally, the infiltrating tumour was poorly differentiated. Benign tubular lesions resembling endosalpingiosis occurred in 16 (40%) of the 40 cases, but in seven it was associated with serous tumour. Psammoma bodies frequently accompanied serous tumour and endosalpingiosis and in occasional cases the majority of lesions consisted of psammomatous foci. The duration of follow up is too short to adequately assess the biological significance of these findings but it is clear that the peritoneal tumour occasionally may kill the patient within a few years. 'Serous tumour of low malignant potential' is the most appropriate term to describe the general group of ovarian serous tumours of so-called 'borderline malignant' type.

References

Dec 1, 1978·The American Journal of Surgical Pathology·A L KatzensteinM S Kao
Apr 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E P MalaiseM Tubiana
Jan 1, 1981·Journal of Clinical Pathology·J S LilleymanB J Laycock
Mar 1, 1982·The American Journal of Surgical Pathology·K R Zinsser, J E Wheeler
Apr 1, 1981·The American Journal of Surgical Pathology·A FoyleW T McCaughey

❮ Previous
Next ❯

Citations

Oct 27, 1998·European Journal of Radiology·P B Van VierzenJ O Barentsz
Feb 24, 2001·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R E Scully
Dec 24, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jaime Prat
Dec 24, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·C Blake GilksDianne M Miller
Jan 1, 1995·Obstetrical & Gynecological Survey·U ElchalalJ G Schenker
Oct 26, 2006·The American Journal of Surgical Pathology·Elvio G SilvaMichael Deavers
Aug 1, 1993·Histopathology·H Fox
Aug 17, 2005·American Journal of Clinical Pathology·Geza Acs
Aug 14, 2013·Annual Review of Pathology·Niloofar N NikRobert J Kurman
Apr 1, 1999·Cancer Investigation·D M Gershenson
Feb 1, 1986·American Journal of Obstetrics and Gynecology·J G Nation, G V Krepart
Apr 1, 1987·Pathology, Research and Practice·D Dienemann, H Pickartz
Mar 1, 2011·Surgical Pathology Clinics·Osama M Al-Agha, C Blake Gilks
Jun 13, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R Ganesan, T Rollason
Sep 17, 2005·Pathology, Research and Practice·Karol KajoJozef Visnovskỳ
Jun 23, 1999·Clinical Oncology : a Journal of the Royal College of Radiologists·S Manek, M Wells
Nov 5, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·David M Gershenson
Sep 1, 2016·Diagnostic Cytopathology·Jefree J Schulte, Ricardo R Lastra
Jul 30, 2005·Gynecologic Oncology·Mark A RettenmaierJohn P Micha
Nov 1, 1992·Gynecologic Oncology·J F LeakeJ D Woodruff
Jul 13, 2017·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Rebecca J WolskyJoseph T Rabban
Apr 2, 1998·Cytopathology : Official Journal of the British Society for Clinical Cytology·C J Stewart, J H Kennedy
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C. W. BurgerP. Kenemans
Oct 14, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Tao ZuoPei Hui
Jan 1, 1996·Cancer Control : Journal of the Moffitt Cancer Center·S V Nicosia
Mar 22, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P MoriceD Castaigne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.